Preface: Special issue "Brain Proteostasis in Health and Disease".
Journal
Journal of neurochemistry
ISSN: 1471-4159
Titre abrégé: J Neurochem
Pays: England
ID NLM: 2985190R
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
18
05
2023
accepted:
18
05
2023
medline:
10
7
2023
pubmed:
7
7
2023
entrez:
6
7
2023
Statut:
ppublish
Résumé
This preface introduces the Journal of Neurochemistry Special Issue on Brain Proteostasis. Adequate control of protein homeostasis, or proteostasis, has been at the center stage of brain physiology, and its deregulation may contribute to brain diseases, including several neuropsychiatric and neurodegenerative conditions. Therefore, delineating the processes underlying protein synthesis, folding, stability, function, and degradation in brain cells is key to promoting brain function and identifying effective therapeutic options for neurological disorders. This special issue comprises four review articles and four original articles covering the roles of protein homeostasis in several mechanisms that are of relevance to sleep, depression, stroke, dementia, and COVID-19. Thus, these articles highlight different aspects of proteostasis regulation in the brain and present important evidence on this growing and exciting field.
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
3-6Subventions
Organisme : Alzheimer's Association
Pays : United States
Informations de copyright
© 2023 International Society for Neurochemistry.
Références
Aguilar-Valles, A., De Gregorio, D., Matta-Camacho, E., Eslamizade, M. J., Khlaifia, A., Skaleka, A., Lopez-Canul, M., Torres-Berrio, A., Bermudez, S., Rurak, G. M., Simard, S., Salmaso, N., Gobbi, G., Lacaille, J. C., Sonenberg, N. (2020). Antidepressant actions of ketamine engage cell-specific translation via eIF4E. Nature, 590, 315-319.
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelley, J. W. (2008). Adapting proteostasis for disease intervention. Science, 319, 916-919.
Bourdenx, M., Martín-Segura, A., Scrivo, A., Rodriguez-Navarro, J. A., Kaushik, S., Tasset, I., Diaz, A., Storm, N. J., Xin, Q., Juste, Y. R., Stevenson, E., Luengo, E., Clement, C. C., Choi, S. J., Krogan, N. J., Mosharov, E. V., Santambrogio, L., Grueninger, F., Collin, L., … Cuervo, A. M. (2021). Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome. Cell, 184, 2696-2714 e2625.
Caetano, F. A., Beraldo, F. H., Hajj, G. N., et al. (2011). Amyloid-beta oligomers increase the localization of prion protein at the cell surface. J Neurochem, 117, 538-553.
Costa-Mattioli, M., Sossin, W. S., Klann, E., & Sonenberg, N. (2009). Translational control of long-lasting synaptic plasticity and memory. Neuron, 61, 10-26.
Costa-Mattioli, M., & Walter, P. (2020). The integrated stress response: From mechanism to disease. Science, 368, eaat5314.
Cozachenco, D., Ribeiro, F. C., & Ferreira, S. T. (2023). Defective proteostasis in Alzheimer's disease. Ageing Research Reviews, 85, 101862.
De Felice, F. G., & Lourenco, M. V. (2015). Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease. Frontiers in Aging Neuroscience, 7, 94.
do Amaral, M. J., Freire, M. H. O., Almeida, M. S., Pinheiro, A. S., & Cordeiro, Y. (2023). Phase separation of the mammalian prion protein: Physiological and pathological perspectives. Journal of Neurochemistry, 166, 58-75.
Duran-Aniotz, C., Poblete, N., Rivera-Krstulovic, C., Ardiles, Á. O., Díaz-Hung, M. L., Tamburini, G., Sabusap, C. M. P., Gerakis, Y., Cabral-Miranda, F., Diaz, J., Fuentealba, M., Arriagada, D., Muñoz, E., Espinoza, S., Martinez, G., Quiroz, G., Sardi, P., Medinas, D. B., Contreras, D., … Hetz, C. (2023). The unfolded protein response transcription factor XBP1s ameliorates Alzheimer's disease by improving synaptic function and proteostasis. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2023.03.028
Hetz, C. (2021). Adapting the proteostasis capacity to sustain brain healthspan. Cell, 184, 1545-1560.
Hetz, C., & Mollereau, B. (2014). Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nature Reviews. Neuroscience, 15, 233-249.
Hipp, M. S., Kasturi, P., & Hartl, F. U. (2019). The proteostasis network and its decline in ageing. Nature Reviews. Molecular Cell Biology, 20, 421-435.
Lepeta, K., Lourenco, M. V., Schweitzer, B. C., Martino Adami, P. V., Banerjee, P., Catuara-Solarz, S., de la Fuente Revenga, M., Guillem, A. M., Haidar, M., Ijomone, O. M., Nadorp, B., Qi, L., Perera, N. D., Refsgaard, L. K., Reid, K. M., Sabbar, M., Sahoo, A., Schaefer, N., Sheean, R. K., … Seidenbecher, C. (2016). Synaptopathies: Synaptic dysfunction in neurological disorders. Journal of Neurochemistry, 138, 785-805.
Lewis, V., Rodrigue, B., Arsenault, E., Zhang, M., Taghavi-Abkuh, F. F., Silva, W. C. C., Myers, M., Matta-Camacho, E., & Aguilar-Valles, A. (2023). Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders. Journal of Neurochemistry, 166, 10-23.
Linden, R., Martins, V. R., Prado, M. A., Cammarota, M., Izquierdo, I., & Brentani, R. R. (2008). Physiology of the prion protein. Physiological Reviews, 88, 673-728.
Liu, R., & Proud, C. G. (2016). Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases. Acta Pharmacologica Sinica, 37, 285-294.
Lodes, D. E., Zhu, J., & Tsai, N. P. (2022). E3 ubiquitin ligase Nedd4-2 exerts neuroprotective effects during endoplasmic reticulum stress. Journal of Neurochemistry, 160, 613-624.
Longo, F., Mancini, M., Ibraheem, P. L., Aryal, S., Mesini, C., Patel, J. C., Penhos, E., Rahman, N., Mamcarz, M., Santini, E., Rice, M. E., & Klann, E. (2021). Cell-type-specific disruption of PERK-eIF2α signaling in dopaminergic neurons alters motor and cognitive function. Molecular Psychiatry, 26, 6427-6450.
Lourenco, M. V., Clarke, J. R., Frozza, R. L., et al. (2013). TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer’s β-amyloid oligomers in mice and monkeys. Cell Metab, 18, 831-843.
Lourenco, M. V., Ferreira, S. T., & De Felice, F. G. (2015). Neuronal stress signaling and eIF2alpha phosphorylation as molecular links between Alzheimer's disease and diabetes. Progress in Neurobiology, 129, 37-57.
Ly, S., Lee, D. A., Strus, E., Prober, D. A., & Naidoo, N. (2020). Evolutionarily conserved regulation of sleep by the protein translational regulator PERK. Current Biology, 30, e1633.
Lyons, L. C., Vanrobaeys, Y., & Abel, T. (2023). Sleep and memory: The impact of sleep deprivation on transcription, translational control, and protein synthesis in the brain. Journal of Neurochemistry, 166, 24-46.
Ma, T. (2023). Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease. Journal of Neurochemistry, 166, 47-57.
Montiel, T., Gómora-García, J. C., Gerónimo-Olvera, C., Heras-Romero, Y., Bernal-Vicente, B. N., Pérez-Martínez, X., Tovar-y-Romo, L. B., & Massieu, L. (2023). Modulation of the autophagy-lysosomal pathway and endoplasmic reticulum stress by ketone bodies in experimental models of stroke. Journal of Neurochemistry, 166, 87-106.
Moreira, G. G., & Gomes, C. M. (2023). Tau liquid-liquid phase separation is modulated by the Ca(2+) -switched chaperone activity of the S100B protein. Journal of Neurochemistry, 166, 76-86.
Oliveira, M. M., & Klann, E. (2022). eIF2-dependent translation initiation: Memory consolidation and disruption in Alzheimer's disease. Seminars in Cell & Developmental Biology, 125, 101-109.
Oliveira, M. M., & Lourenco, M. V. (2016). Integrated stress response: Connecting ApoE4 to memory impairment in Alzheimer's disease. Journal of Neuroscience, 36, 1053-1055.
Oliveira, M. M., Lourenco, M. V., Longo, F., et al. (2021). Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer’s disease. Science Signaling, 14, eabc5429.
Ostapchenko, V. G., Beraldo, F. H., Mohammad, A. H., et al. (2013). The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-beta oligomer toxicity. J Neurosci, 33, 16552-16564.
Santini, E., Huynh, T. N., MacAskill, A. F., Carter, A. G., Pierre, P., Ruggero, D., Kaphzan, H., & Klann, E. (2013). Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature, 493, 411-415.
Sharma, V., Sood, R., Lou, D., Hung, T. Y., Lévesque, M., Han, Y., Levett, J. Y., Wang, P., Murthy, S., Tansley, S., Wang, S., Siddiqui, N., Tahmasebi, S., Rosenblum, K., Avoli, M., Lacaille, J. C., Sonenberg, N., & Khoutorsky, A. (2021). 4E-BP2-dependent translation in parvalbumin neurons controls epileptic seizure threshold. Proceedings of the National Academy of Sciences, 118. e2025522118, https://doi.org/10.1073/pnas.2025522118
Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A., Wisniewski, T., Gunther, E. C., & Strittmatter, S. M. (2012). Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci, 15, 1227-1235.
Wiebe, S., Nagpal, A., Truong, V. T., Park, J., Skalecka, A., He, A. J., Gamache, K., Khoutorsky, A., Gantois, I., & Sonenberg, N. (2019). Inhibitory interneurons mediate autism-associated behaviors via 4E-BP2. Proceedings of the National Academy of Sciences of the United States of America, 116, 18060-18067.
Ziff, O. J., Ashton, N. J., Mehta, P. R., Brown, R., Athauda, D., Heaney, J., Heslegrave, A. J., Benedet, A. L., Blennow, K., Checkley, A. M., Houlihan, C. F., Gauthier, S., Rosa-Neto, P., Fox, N. C., Schott, J. M., Zetterberg, H., Benjamin, L. A., & Paterson, R. W. (2022). Amyloid processing in COVID-19-associated neurological syndromes. Journal of Neurochemistry, 161, 146-157.